Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.
about
MAIT cells: new guardians of the liverHepatitis C virus infection.Multiple layers of heterogeneity and subset diversity in human MAIT cell responses to distinct microorganisms and to innate cytokines.Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during TherapyMAIT cells are reduced in frequency and functionally impaired in human T lymphotropic virus type 1 infection: Potential clinical implications.The role of mucosal-associated invariant T cells in infectious diseases.The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?Designing an HCV vaccine: a unique convergence of prevention and therapy?Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals.Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.Direct-Acting Antiviral-Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C.MAIT be different-persisting dysfunction after DAA-mediated clearance of chronic hepatitis C virus infection.Mucosal-associated invariant T (MAIT) cells are more activated in chronic hepatitis B, but not depleted in blood: reversal by antiviral therapy.Interactions between bile salts, gut microbiota, and hepatic innate immunity.Mucosal-Associated Invariant T Cells in Regenerative Medicine.MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection.MAIT cells and Viruses.Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis.Role of MAIT cells in the immunopathogenesis of inflammatory diseases: New players in old game.The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161lo T (MAIT-like) cells in the pathogenesis of early-onset pre-eclampsia.Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment.Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells.Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity.Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies.Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.The Role of CD1d and MR1 Restricted T Cells in the LiverImmune Alterations in Patients With Type 1 Autoimmune Hepatitis Persist Upon Standard Immunosuppressive Treatment
P2860
Q28073095-F45D83AE-644C-4B39-B305-D8493036BE87Q30235491-F0FCF9A0-B3F7-4CD6-9687-F9EA9639B266Q33887115-117E6735-D96A-4D4D-B0DD-663D81AF9233Q36077824-9FD0F7A9-94F1-47DF-AA28-0B2DCB3B2555Q36338406-11E52DD3-3C8E-4DDE-8EFC-714DB40AE225Q38955495-D952AD96-7D79-41F3-939A-50EED5E59781Q39030356-F79109FC-32AF-4E1C-B939-3ECF0C25ECB2Q39333862-112DFF85-321E-422E-89E1-9E98573BF067Q40060728-59EB1CF0-F5BB-4A90-8F60-21EBE8B2FA1AQ40093638-94DE5A24-7E2A-40CB-9A69-262554B209FDQ40100401-F926B585-E81E-4488-8C7C-C627F932D02CQ40523304-0AC7E7AF-180F-4A67-8253-94AA6F248A10Q40593130-07603A33-D4DF-46F0-BAEE-065FA33C35C1Q41926537-55402A29-1C21-4480-B434-35D488F57AC6Q46314074-0BCD1627-A7AD-4E28-A238-30F1BB5C349BQ47241753-341F2636-BADC-4A42-B6CB-AE542BF267DBQ47550378-66EF1B2F-2875-44D3-A8E0-26B31DF6CE99Q47551345-D850933B-D088-4017-8D3A-CCA85B4D41B9Q47569554-DDA24D13-CA3A-44A3-907E-24AAB0F71933Q47589231-2C54030C-6E7B-4219-BB98-17A23B6938D2Q48371088-E1CB75EB-4E88-4C1E-AE69-D1A9D1BCCE48Q52332749-7F45D25E-5FCC-4616-86C6-81ABC10007A5Q52605839-86909B81-70A1-414D-8D64-220364E2641FQ54217620-CFE3140E-9B38-4D59-BF6C-AB0C51EE9815Q55097758-53453C73-1747-4252-AA9A-05AD972AE234Q55284802-E8911EBF-DC6A-4287-9CEB-0437125AC3E3Q55717169-C487B9B9-DB3A-4EE2-AAA9-E1E590BF3D84Q58697988-69B2D0DA-858F-4107-B858-91C91C0F4B22Q58799838-75F8CAEA-FEEC-4354-8EB6-C90AD14285BE
P2860
Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Nonreversible MAIT cell-dysfun ...... ssful interferon-free therapy.
@en
type
label
Nonreversible MAIT cell-dysfun ...... ssful interferon-free therapy.
@en
prefLabel
Nonreversible MAIT cell-dysfun ...... ssful interferon-free therapy.
@en
P2093
P2860
P50
P356
P1476
Nonreversible MAIT cell-dysfun ...... ssful interferon-free therapy.
@en
P2093
Benedikt Strunz
Hans-Gustaf Ljunggren
Heiner Wedemeyer
Julia Hengst
Katja Deterding
Michael P Manns
P2860
P304
P356
10.1002/EJI.201646447
P407
P577
2016-06-14T00:00:00Z